HemaSphere Editorial Board
Editor-in-Chief
- Jan Cools, Belgium
Deputy Editor-in-Chief
- Claire Harrison, United Kingdom
Associate Editors
- Stephen Ansell, USA
- Martin Dreyling, Germany
- Jeroen Eikenboom, The Netherlands
- Adele Fielding, United Kingdom
- Paolo Ghia, Italy
- Simon Hallam, United Kingdom
- Robert Hills, United Kingdom
- Steffen Koschmieder, Germany
- Martina Mückenthaler, Germany
- Paula Rodríguez Otero, Spain
- Juerg Schwaller, Switzerland
- Evangelos Terpos, Greece
Scientific Editors
- Stephen Hibbs, United Kingdom
- David Kent, United Kingdom
- Roger Schutgens, The Netherlands
- Melania Tesio, France
- Francesca Vinchi, USA
Aim
HemaSphere publishes results of highly relevant basic, translational, and clinical research in hematology. We are especially looking for strong studies reporting novel findings that are of high impact to the field of hematology. Review articles, Guideline articles, and Controversy articles provide clear overviews and discussions of new developments as well as recommendations for patient care.
HemaSphere is also the premier hematology information resource, which is covered by the HemaTopics section in the journal. This section provides insightful discussions on all aspects related to hematology, including summaries of important articles, reports of new therapies, discussions on EU policy, EHA news, and other hematology news items.
HemaSphere is an open access journal, powered by the European Hematology Association, and dedicated to support hematology patient care, research and education worldwide.
HemaSphere is proud to have a 2022 Journal Impact Factor (JIF) of 9.1 (source: Journal Citation Reports, Clarivate). HemaSphere also has a Scopus 2022 CiteScore of 5.3. HemaSphere is fully indexed in PubMed Central (PMC), is a member of the Science Citation Expanded Index (SCIE) – Hematology, and is listed on the Directory of Open Access Journals (DOAJ).
HemaSphere has been accepted for inclusion and fully indexed in PubMed Central (PMC). The journal has also been selected for coverage in Clarivate Analytics’ Emerging Sources Citation Index (ESCI) and is listed on the Directory of Open Access Journals (DOAJ).
Tasks and responsibilities
- The Editorial Board is led by the Editor in Chief.
- Under the leadership of the Editor in Chief, the Editorial Board is responsible for:
- The timely review and selection of articles that serve the aims and scope of HemaSphere
- The promotion of HemaSphere within the hematology community and beyond
- Representing HemaSphere at various occasions
- Guiding the quality and growth HemaSphere to become a reputable society journal for European hematology research and related scientific news
- Actively participate in meetings and calls.
Composition
- Editor in Chief fixed advisors EHA Board
- Deputy Editor in Chief
- Up to 15 Associate Editors
- Up to 6 Scientific Editors
Rotation
- 3 years with the possibility of reappointment once
Meetings
- 2-3 physical meetings
- Regular conference calls
Back